Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

10.75p
   
  • Change Today:
      0.79p
  • 52 Week High: 50.40p
  • 52 Week Low: 6.75p
  • Currency: UK Pounds
  • Shares Issued: 189.93m
  • Volume: 1,207,007
  • Market Cap: £20.42m
  • RiskGrade: 348
  • Beta: 1.27

Renalytix secures expanded coverage in Washington, DC area

By Josh White

Date: Monday 22 May 2023

LONDON (ShareCast) - (Sharecast News) - Kidney disease diagnostics developer Renalytix announced the expansion of insurance coverage in the US for its flagship product KidneyIntelX on Monday.
The AIM-traded firm said the expansion was secured with CareFirst BlueCross BlueShield- the largest healthcare plan in the mid-Atlantic region, serving 3.4 million members around Washington - in Maryland, the District of Columbia, and northern Virginia.

It said the partnership also included coverage for the Federal Employee Program (FEP), which is part of the Federal Employees Health Benefits (FEHB) programme administered by CareFirst.

"This agreement complements coverage already secured with Wellmark Blue Cross Blue Shield in Iowa and South Dakota - estimated 2.1 million covered lives- and BlueCross BlueShield of Illinois - estimated 8.1 million covered lives," the Renalytix board said in its statement.

At 1118 BST, shares in Renalytix were up 1.6% in London, at 88.9p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 10.75p
Change Today 0.79p
% Change 7.93 %
52 Week High 50.40p
52 Week Low 6.75p
Volume 1,207,007
Shares Issued 189.93m
Market Cap £20.42m
Beta 1.27
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
16.43% above the market average16.43% above the market average16.43% above the market average16.43% above the market average16.43% above the market average
65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average
Price Trend
76.86% below the market average76.86% below the market average76.86% below the market average76.86% below the market average76.86% below the market average
67.57% below the sector average67.57% below the sector average67.57% below the sector average67.57% below the sector average67.57% below the sector average
Income Not Available
Growth
34.7% below the market average34.7% below the market average34.7% below the market average34.7% below the market average34.7% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

RENX Dividends

No dividends found

Trades for 24-Dec-2024

Time Volume / Share Price
11:37 250,000 @ 10.50p
11:24 200,000 @ 10.50p
12:15 1,822 @ 10.98p
12:06 4,625 @ 10.81p
11:53 46,253 @ 10.81p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page